BE.Amycon Registry UZ Leuven

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Total Enrollment

550 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2028-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to establish database with (limited) personal and health data of patients diagnosed with amyloidosis (any subtype) in order to get better insights on the disease presentation, disease evolution pattern, treatment plans and responses and survival.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Registry of AL Amyloidosis (ReAL)

NCT04839003

AL Amyloidosis

RECRUITING

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

NCT04569903

Transthyretin Amyloidosis

WITHDRAWN EARLY_PHASE1

Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

NCT06059053

Aortic Aneurysm Endovascular Aortic Repair Stent-Graft Endoleak

RECRUITING

Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis

NCT06034405

Lumbar Spinal Stenosis Cardiac Amyloidosis ATTR Amyloidosis Wild Type +3 more

RECRUITING

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

NCT03431896

Amyloidosis Amyloid Amyloid Neuropathies, Familial +4 more

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With the support of VIB Grand Challenges Program, this project aims to establish the BElgian AMYloidosis CONsortium (BE.AMYCON) by joining forces of VIB researchers, a state-of-the-art diagnostic platform, and clinicians from various disciplines and different institutes. Such a consortium will address patient needs and improve outcomes on many levels.

In this context, a registry of clinical data is a requirement for both improvement of diagnostics as well as fundamental research purposes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amyloidosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Registry

observational data collection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older
* Provide consent and sign informed consent form
* Confirmed diagnosis of amyloidosis (any subtype), systemic and/or localised
* Newly diagnosed or in follow-up during the study time-frame (1 JUN 2025 until 31 DEC 2027)